Skip to Content

Deferoxamine Injection

Last Updated: May 25, 2018
Status: Current

Products Affected - Description
    • Desferal injection, Novartis, 500 mg, vial, 4 count, NDC 00078-0467-91
    • Deferoxamine injection, Fresenius Kabi, 2 gram, vial, 1 count, NDC 63323-0599-30
    • Deferoxamine injection, Pfizer, 2 gram, vial, 4 count, NDC 00409-2337-25
    • Deferoxamine injection, Pfizer, 500 mg, vial, 4 count, NDC 00409-2336-10
Reason for the Shortage
    • Fresenius Kabi has deferoxamine on shortage due to increased demand.
    • Pfizer has deferoxamine on shortage due to manufacturing delays.
    • Novartis has Desferal on shortage due to increased demand.
Available Products
    • Deferoxamine injection, Fresenius Kabi, 500 mg, vial, 1 count, NDC 63323-0597-10

Estimated Resupply Dates

    • Fresenius Kabi has deferoxamine 2 gram vials on back order and the company estimates a release date of mid-June 2018. Check wholesalers for inventory.
    • Pfizer has deferoxamine 500 mg and 2 gram vials on back order and the company estimates a release date of 2019. Pfizer has a limited supply of short-dated 2 gram vials.
    • Novartis has Desferal 500 mg vials on allocation

Updated

Updated May 25, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 7, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide